ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.39
+0.57 (7.29%)
At close: Mar 13, 2026, 4:00 PM EDT
8.40
+0.01 (0.12%)
After-hours: Mar 13, 2026, 7:59 PM EDT

ImmunityBio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-351.47-413.65-583.85-417.32-349.85
Depreciation & Amortization
15.5317.5518.5118.2614.24
Stock-Based Compensation
36.8134.4349.1640.1857.18
Other Adjustments
48.53-10.16145.5929.3723.12
Change in Receivables
-40.21-2.36---
Changes in Inventories
-6.33-8.27---
Changes in Accounts Payable
-0.19-3.17-6.488-3.72
Changes in Accrued Expenses
3.18-1.516.694.15.18
Changes in Other Operating Activities
-10.79-4.123.62-20.1-20.58
Operating Cash Flow
-304.94-391.24-366.76-337.51-274.42
Capital Expenditures
-3.85-6.89-30.58-78.16-33.56
Sale of Property, Plant & Equipment
----20.5
Purchases of Intangible Assets
-0.41---21.23-
Purchases of Investments
-241.37-140.22-10.36-35.31-141.75
Proceeds from Sale of Investments
95.82136.6110.4716269.93
Payments for Business Acquisitions
--1---
Other Investing Activities
--0.75---
Investing Cash Flow
-149.8-12.25-30.4727.3-84.89
Short-Term Debt Issued
2.88----
Net Short-Term Debt Issued (Repaid)
2.88----
Long-Term Debt Issued
-96.96451.46174.13338.5
Net Long-Term Debt Issued (Repaid)
-96.96451.46174.13338.5
Issuance of Common Stock
400.78190.2110.460.5169.99
Repurchase of Common Stock
-2.27-5.47-3.44-0.62-4.06
Net Common Stock Issued (Repurchased)
398.52184.74106.9559.89165.93
Other Financing Activities
-1.16-0.06-0.08-0.41.02
Financing Cash Flow
400.24281.63558.34233.61505.44
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.02-0.02-0.290.280.05
Net Cash Flow
-54.48-121.88160.82-76.32146.19
Free Cash Flow
-308.78-398.12-397.34-415.67-307.98
FCF Margin
-272.56%-2700.06%-63881.19%-173196.25%-32974.52%
Free Cash Flow Per Share
-0.34-0.57-0.78-1.04-0.79
Levered Free Cash Flow
-350.95-323-139.98-310.35-46.73
Unlevered Free Cash Flow
-258.37-350.58-370.47-419.23-368.73
Updated Feb 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q